Literature DB >> 16172626

Aseptic meningitis after intrathecal baclofen injection.

D Bensmail1, A Peskine, P Denys, L Bernard, B Bussel.   

Abstract

STUDY
DESIGN: Two case reports of aseptic meningitis after intrathecal baclofen injection.
OBJECTIVES: To report an unusual complication of intrathecal baclofen injection during test injections.
SETTING: Department of Neurological Rehabilitation, R Poincaré Hôpital (Paris-Ile de France-Ouest University). CASE REPORTS: We present two cases of chemical meningitis after intrathecal baclofen injections by lumbar puncture. These cases presented with febrile meningeal syndromes during the 24 h following intrathecal baclofen injection. Direct cerebrospinal fluid (CSF) examination and CSF cultures were negative. An intense cellular reaction was observed with a marked predominance of neutrophils. Meningitis resolved spontaneously over 3-4 days.
CONCLUSIONS: Chemical meningitis is a rare complication of intrathecal baclofen injections that must be recognized. It is a diagnosis of exclusion and its pathophysiological mechanism remains unclear. Spinal Cord (2006) 44, 330-333. doi:10.1038/sj.sc.3101838; published online 20 September 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16172626     DOI: 10.1038/sj.sc.3101838

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

Review 1.  Intrathecal baclofen for childhood hypertonia.

Authors:  A Leland Albright
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

Review 2.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 3.  Chronic meningitis.

Authors:  Raimund Helbok; Gregor Broessner; Bettina Pfausler; Erich Schmutzhard
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.